Soriot points out that Europe now faces a double threat. On one hand, major pharmaceutical companies are investing heavily in the United States to avoid their products being heavily taxed by the Trump administration. On the other, China is already a leader in generics and has become a formidable competitor in innovative medicines.
Pascal Soriot is the highest paid CEO in the United Kingdom.
According to the Financial Times, he was paid £16.9 million last year. Despite this, he privately told the chairman of the board that he isn’t satisfied with his compensation. He wants to be paid far more.
https://www.ft.com/content/fb9f6c33-c745-468b-bb21-cd253b448e44
https://www.ft.com/content/c7226781-b45b-4502-ba38-129dea5e960e
Some questions for Mr. Soriot.
1. If the Drug Industry is as competitive as you claim, how can it afford to pay such lavish compensation?
2. How much money is paid to your average researcher?
3. Why do you systematically compare yourself to US CEOs? Why don’t you compare yourself to Chinese CEOs?